Difference in by Akihiro Kakimoto (343218)

“…The educational effectiveness was evaluated using a multiple-choice cognitive test. Compared with the resting levels, the alpha/beta ratio of EEG (indicating relaxed concentration) was significantly decreased by 19% in the video-based VR and increased by 40% in the immersive VR groups (both p < 0.05). …”

Experimental protocol. by Akihiro Kakimoto (343218)

“…The educational effectiveness was evaluated using a multiple-choice cognitive test. Compared with the resting levels, the alpha/beta ratio of EEG (indicating relaxed concentration) was significantly decreased by 19% in the video-based VR and increased by 40% in the immersive VR groups (both p < 0.05). …”

Adverse events and treatment interruptions. by Nicola Squillace (691608)

“…At T1, ART-experienced PLWH showed a significant reduction of total cholesterol (TC) and triglycerides, and a slight increase in blood glucose (BG) and ALT. …”

Flow chart of the treatment interruptions. by Nicola Squillace (691608)

“…At T1, ART-experienced PLWH showed a significant reduction of total cholesterol (TC) and triglycerides, and a slight increase in blood glucose (BG) and ALT. …”

Relationship between the change in by Akihiro Kakimoto (343218)

“…The educational effectiveness was evaluated using a multiple-choice cognitive test. Compared with the resting levels, the alpha/beta ratio of EEG (indicating relaxed concentration) was significantly decreased by 19% in the video-based VR and increased by 40% in the immersive VR groups (both p < 0.05). …”

Characteristics of the included studies. by Xin Liu (43569)

“…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”

Summary of results. by Xin Liu (43569)

“…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”

Bias risk assessments for each RCT study. by Xin Liu (43569)

“…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”

The flow chart of studies selecting. by Xin Liu (43569)

“…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”

Funnel plots for intraoperative blood loss. by Xin Liu (43569)

“…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”

Bias risk assessments for each RCS study. by Xin Liu (43569)

“…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …”

TIRF analyses of pericentrin-depleted MIN6 cells at non-stimulatory glucose concentration (2.5 mM) show increase in docked insulin granules and decrease at stimulatory glucose conc... by Agata Jurczyk (245201)

Violin plots showing the distribution of IB-DE and IB-4 across samples and sexes. by Aistė Ambrasė (22505574)

Heat map of the Pearson correlation coefficients between progress test scores across test administrations from 2017 to 2024. by Franco Romaní-Romaní (21989788)

Scatter plot of scores in the first six progress tests by entry cohort. by Franco Romaní-Romaní (21989788)

Omeprazole (Ome) does not increase IL-4-stimulated eotaxin-3 mRNA degradation, and does not decrease STAT6 phosphorylation or nulcear translocation in EoE1-T and EoE2-T cell lines. by Xi Zhang (83736)

Gastrocnemius muscle mass normalized to body weight and force recovery 14 days post-reperfusion after saline injection or the delivery of 2x10⁶<i>in vitro</i> polarized... by Viktoriya Rybalko (840821)

Analysis of the myofiber distribution 14 days post-reperfusion in GAS muscles treated with saline or 2x10⁶<i>in vitro</i> polarized macrophages 24h after TK-I/R injury. by Viktoriya Rybalko (840821)

Overall survival and responses to autoantibody reduction therapy. by Tejaswini Kulkarni (716851)

Influence of Familial Renal Glycosuria Due to Mutations in the <i>SLC5A2</i> Gene on Changes in Glucose Tolerance over Time by Emilia Ottosson-Laakso (843794)

“…Several drugs have been introduced as means to lower glucose in patients with type 2 diabetes targeting SGLT2 resulting in renal glycosuria, but no studies have addressed the potential effects of decreased renal glucose reabsorption and chronic glycosuria on the prevention of glucose intolerance. …”